S Kaye Selected Research

S Kaye Research Topics

Disease

14	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 05/2000
9	Neoplasms (Cancer) 03/2017 - 07/2000
6	Infections 01/2017 - 11/2000
4	Fatigue 09/2012 - 10/2004
4	Ovarian Epithelial Carcinoma 06/2008 - 05/2000
3	HIV Infections (HIV Infection) 11/2017 - 03/2012
3	Viremia 11/2016 - 01/2001
3	Neutropenia 04/2014 - 11/2004
3	Disease Progression 02/2009 - 12/2007
2	Neoplasm Metastasis (Metastasis) 09/2012 - 03/2008
2	Nausea 11/2011 - 12/2007
2	Fibrosis (Cirrhosis) 02/2010 - 08/2008
2	Melanoma (Melanoma, Malignant) 12/2009 - 09/2006
2	Vomiting 12/2007 - 01/2007
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2001 - 11/2000
1	Weight Loss (Weight Reduction) 01/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2017
1	Tick Paralysis (Paralysis, Tick) 08/2016
1	Low Vision (Subnormal Vision) 07/2015
1	Generalized Essential Telangiectasia 07/2015
1	Hypersensitivity (Allergy) 04/2014
1	Seizures (Absence Seizure) 12/2013
1	Prostatic Neoplasms (Prostate Cancer) 05/2013
1	Lymphoma (Lymphomas) 09/2012
1	Arthralgia (Joint Pain) 11/2011
1	Hepatocellular Carcinoma (Hepatoma) 02/2010
1	Liver Neoplasms (Liver Cancer) 08/2008
1	Liver Diseases (Liver Disease) 08/2008
1	Exanthema (Rash) 09/2006
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 10/2005

Drug/Important Bio-Agent (IBA)

7	Carboplatin (JM8)FDA LinkGeneric 04/2014 - 08/2004
6	PlatinumIBA 04/2014 - 01/2006
4	DNA (Deoxyribonucleic Acid)IBA 04/2014 - 09/2001
4	Paclitaxel (Taxol)FDA LinkGeneric 05/2012 - 05/2000
3	Pharmaceutical PreparationsIBA 11/2011 - 09/2006
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2005 - 05/2000
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2016 - 05/2013
2	Cytotoxins (Cytolysins)IBA 01/2014 - 09/2001
2	Transaminases (Aminotransferases)IBA 09/2012 - 11/2004
2	liposomal doxorubicin (Doxil)FDA Link 09/2009 - 10/2001
2	OligonucleotidesIBA 08/2008 - 09/2001
2	Docetaxel (Taxotere)FDA Link 06/2008 - 01/2006
2	Gemcitabine FDA Link 01/2006 - 08/2004
2	Capecitabine (Xeloda)FDA Link 01/2006 - 09/2001
2	RNA (Ribonucleic Acid)IBA 10/2005 - 04/2005
2	Cisplatin (Platino)FDA LinkGeneric 11/2003 - 05/2000
2	dl1520 (ONYX-015)IBA 01/2001 - 11/2000
1	LipidsIBA 01/2018
1	HDL LipoproteinsIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 11/2017
1	Intravenous Immunoglobulins (IVIG)FDA Link 11/2017
1	Maraviroc FDA Link 01/2017
1	Antiviral Agents (Antivirals)IBA 11/2016
1	pro-brain natriuretic peptide (1-76)IBA 08/2016
1	Troponin IIBA 08/2016
1	olaparibIBA 01/2016
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 07/2015
1	Fluorescein (Funduscein)FDA LinkGeneric 07/2015
1	Decitabine FDA Link 04/2014
1	phenoxodiolIBA 01/2014
1	Biological ProductsIBA 12/2013
1	Cocaine (Cocaine HCl)IBA 12/2013
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2013
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 09/2012
1	Alanine Transaminase (SGPT)IBA 09/2012
1	Dihydrotachysterol (AT 10)IBA 09/2012
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2012
1	saracatinibIBA 05/2012
1	Narcotics (Narcotic Analgesics)IBA 03/2012
1	sagopiloneIBA 11/2011
1	Epothilones (Epothilone)IBA 11/2011
1	Biomarkers (Surrogate Marker)IBA 02/2010
1	Hepatitis B e AntigensIBA 02/2010
1	Proteins (Proteins, Gene)FDA Link 12/2009
1	AntibodiesIBA 12/2009
1	Messenger RNA (mRNA)IBA 12/2009
1	TER 286 (TLK286)IBA 09/2009
1	1-dodecylpyridoxal (PLD)IBA 09/2009
1	Topotecan (Hycamtin)FDA LinkGeneric 09/2009
1	trioctyl phosphine oxide (TOPO)IBA 09/2009
1	EpitopesIBA 02/2009
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 08/2008
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2008
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2008
1	AlbuminsIBA 03/2008
1	Alanine (L-Alanine)FDA Link 12/2007
1	TrabectedinIBA 12/2007
1	TransferasesIBA 12/2007
1	CreatinineIBA 01/2007
1	Sorafenib (BAY 43-9006)FDA Link 09/2006
1	Epirubicin (Ellence)FDA LinkGeneric 01/2006
1	Viral RNAIBA 10/2005

Therapy/Procedure

13	Therapeutics 03/2017 - 11/2004
6	Drug Therapy (Chemotherapy) 01/2016 - 11/2003
2	Art Therapy 11/2017 - 04/2005
2	TP protocol 11/2003 - 05/2000
1	Secondary Prevention 03/2017
1	Semiconductors 11/2016
1	Ligation 08/2008
1	Combination Drug Therapy (Combination Chemotherapy) 01/2006